Premier Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Premier Asset Management's AZN Position: Q1 2019 in Review
Premier Asset Management sold out of AstraZeneca (AZN) in Q1 2019, closing a stake of 16,350 shares — an estimated $1.24M sold.
Premier Asset Management first reported a position in AZN in Q3 2013 and held it in 22 quarters. The position peaked at $1.5M in Q3 2016. 561 funds tracked by Wall St. Rank hold AZN as of Q1 2019.
- Premier Asset Management reported no remaining AstraZeneca position as of Q1 2019 after selling out during the quarter.
- Premier Asset Management sold 16,350 AstraZeneca shares in Q1 2019, an estimated $1.24M.
- Premier Asset Management first reported a position in AstraZeneca in Q3 2013 and held it in 22 quarters.
- Premier Asset Management's AstraZeneca position peaked at $1.5M in Q3 2016.
- 561 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2019.
Based on Premier Asset Management's 13F filing for Q1 2019, filed 15 May 2019.